Author/Authors :
Radisic, M. V. Infectious Diseases Department - d. Institute. Instituto de Trasplante y Alta Complejidad (ITAC) - Ciudad Autónoma de Buenos Aires, Argentina , Walther, J. C. Nephrology Department - ITAC - Ciudad Autónoma de Buenos Aires, Argentina , Werber, G Intensive Care Unit - ITAC - Ciudad Autónoma de Buenos Aires, Argentina , Pujato, N Infectious Diseases Department - d. Institute. Instituto de Trasplante y Alta Complejidad (ITAC) - Ciudad Autónoma de Buenos Aires, Argentina , Beltramino, S Intensive Care Unit - ITAC - Ciudad Autónoma de Buenos Aires, Argentina , . Bravo, P.M Infectious Diseases Department - d. Institute. Instituto de Trasplante y Alta Complejidad (ITAC) - Ciudad Autónoma de Buenos Aires, Argentina , Bello, A Nephrology Department - ITAC - Ciudad Autónoma de Buenos Aires, Argentina , Hunter, M Internal Medicine Department - ITAC - Ciudad Autónoma de Buenos Aires, Argentina
Abstract :
When it is safe to proceed with transplantation after coronavirus disease 2019 (COVID-19) infection
is still unknown. We describe the clinical course and management of immunosuppression in
a patient with positive real-time polymerase chain reaction (RT-PCR) for Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) in a nasopharyngeal swab at the time of kidney transplantation,
and with positive antibodies for SARS-CoV-2. The patient had no complications and was
discharged with a functioning graft.
